Drug intelligence / Profile preview

Hibisol

Development stage
Unknown
Lead developer
Regent Medical
Modality
Small Molecules
Administration
Topical
01

Overview

Hibisol is a topical antiseptic solution containing chlorhexidine gluconate and isopropyl alcohol, originally developed by Regent Medical (now part of Mölnlycke Health Care). It is primarily indicated for the disinfection of skin prior to invasive medical procedures and as a hand rub for healthcare professionals to prevent cross-infection. The drug's mechanism of action involves the cationic binding of chlorhexidine to bacterial cell membranes, leading to their disruption, while isopropyl alcohol provides rapid antimicrobial activity through the denaturation of microbial proteins. Following a name change, the product is also marketed as 'HiBi Liquid Hand Rub+'. It has been evaluated in Phase 4 dermatological safety studies to compare its skin irritation potential against other antiseptic formulations using transepidermal water loss (TEWL) assessments.

Brand names
HibisolHiBi Liquid Hand Rub+
Other names
chlorhexidine gluconate + isopropyl alcohol

Beyond the preview

Go deeper on Hibisol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hibisol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call